329 results on '"Schandelmaier, P."'
Search Results
2. Immunohistochemical Detection of Indoleamine 2,3-Dioxygenase in Spontaneous Mammary Carcinomas of 96 Pet Rabbits
- Author
-
Sandra Schöniger, Sophie Degner, Claudia Schandelmaier, Heike Aupperle-Lellbach, Qian Zhang, and Hans-Ulrich Schildhaus
- Subjects
breast cancer research ,mammary carcinoma ,immunohistochemistry ,immuno-oncology ,indoleamine 2,3-dioxygenase 1 (IDO1) ,rabbit ,Veterinary medicine ,SF600-1100 ,Zoology ,QL1-991 - Abstract
For mammary carcinomas in pet rabbits, prognostic biomarkers are poorly defined, and treatment is limited to surgical excision. Additional treatment options are needed for rabbit patients for which surgery is not a suitable option. In human breast cancer, the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1) represents a prognostic biomarker and possible therapeutic target. This retrospective immunohistochemical study examined IDO1 in 96 pet rabbit mammary carcinomas with known mitotic count, hormone receptor status, and percentage of stromal tumor infiltrating lymphocytes (TILs). Tumors were obtained from 96 pet rabbits with an average of 5.5 years. All rabbits with reported sex (n = 88) were female or female-spayed. Of the carcinomas, 94% expressed IDO1, and 86% had sparse TILs consistent with cold tumors. Statistically significant correlations existed between a higher percentage of IDO1-positive tumor cells, lower mitotic counts, and increased estrogen receptor expression. The threshold for significance was IDO1 staining in >10% of tumor cells. These results lead to the assumption that IDO1 expression contributes to tumorigenesis and may represent a prognostic biomarker and possible therapeutic target also in pet rabbit mammary carcinomas. They also support the value of rabbits for breast cancer research.
- Published
- 2024
- Full Text
- View/download PDF
3. Headache frequency and neck pain are associated with trapezius muscle T2 in tension-type headache among young adults
- Author
-
Nico Sollmann, Paul Schandelmaier, Dominik Weidlich, Jonathan Stelter, Gabby B. Joseph, Corinna Börner, Severin Schramm, Meinrad Beer, Claus Zimmer, Mirjam N. Landgraf, Florian Heinen, Dimitrios C. Karampinos, Thomas Baum, and Michaela V. Bonfert
- Subjects
Magnetic resonance imaging ,Migraine ,Tension-type headache ,Trapezius muscle ,T2 mapping ,Trigemino-cervical complex ,Medicine - Abstract
Abstract Background Tension-type headache (TTH) is the most prevalent primary headache disorder. Neck pain is commonly associated with primary headaches and the trigemino-cervical complex (TCC) refers to the convergence of trigeminal and cervical afferents onto neurons of the brainstem, thus conceptualizes the emergence of headache in relation to neck pain. However, no objective biomarkers exist for the myofascial involvement in primary headaches. This study aimed to investigate the involvement of the trapezius muscles in primary headache disorders by quantitative magnetic resonance imaging (MRI), and to explore associations between muscle T2 values and headache frequency and neck pain. Methods This cohort study prospectively enrolled fifty participants (41 females, age range 20–31 years): 16 subjects with TTH only (TTH-), 12 with mixed-type TTH plus migraine (TTH+), and 22 healthy controls (HC). The participants completed fat-suppressed T2‐prepared three-dimensional turbo spin-echo MRI, a headache diary (over 30 days prior to MRI), manual palpation (two weeks before MRI), and evaluation of neck pain (on the day of MRI). The bilateral trapezius muscles were manually segmented, followed by muscle T2 extraction. Associations between muscle T2 and the presence of neck pain as well as the number of days with headache (considering the 30 days prior to imaging using the headache calendar) were analyzed using regression models (adjusting for age, sex, and body mass index). Results The TTH+ group demonstrated the highest muscle T2 values (right side: 31.4 ± 1.2 ms, left side: 31.4 ± 0.8 ms) as compared to the TTH- group or HC group (p
- Published
- 2023
- Full Text
- View/download PDF
4. The Interobserver Reliability of Grading of Distal Radius Volar Plate Prominence
- Author
-
Akabudike, N.M., Apard, T., Bafus, B.T., Ballas, E.G., Bamberger, H.B., Baxamusa, T., Begue, T.C., Belangero, W.D., Benhaim, P., Biert, J., Blazar, P., Bloemers, F.W., Borris, L.C., Brink, O., Brubacher, J.W., Buckley, R., Calcagni, M., Calfee, R.P., Campbell, S.T., Chepla, K.J., Choudhari, P., Conflitti, J.M., Coomber, R., de Bedout, R., Debeij, J., DeCoster, T., DeSilva, G., Domenech, J., Draeger, R.W., Dwyer, C.L., Elias, N., Erickson, J.M., Evans, P.J., Farr, S., Fernandes, C.H., Fricker, R., Garnavos, C., Gilbert, R.S., Giordano, V., Goost, H., Gosens, T., Guitton, T.G., Hammert, W.C., Havlicek, T., Hearon, B.F., Henry, S.L., Hobby, J.L., Hodel, S., Hofmeister, E.P., Huang, J.I., Jebson, P., Jenkinson, R., Jeray, K., Kabir, K., Kanakaris, N.K., Kaplan, F.T.D., Kennedy, S.A., Klostermann, C., Knobe, M., Kraan, G.A., Kristan, A., Lane, L.B., Lawson McLean, A., Lightdale-Miric, N., Metzger, C.L., Mica, L., Miranda, G.V., Mirck, B., Mitchell, S., Mittlmeier, T., Moreno-Serrano, C.L., Nancollas, M.P., Ortiz, J.A., Jr., Peters, A., Pianka, G., Pirpiris, M., Poelhekke, L.M.S.J., Prkic, A., Prommersberger, K.J., Raven, E.E.J., Rizzo, M., Rodner, C., Rodríguez Roiz, J.M., Rohde, R.S., Romero, C.J., Sandoval, J., Schandelmaier, P., Schep, N.W.L., Schepers, T., Schiffer, G., Seibert, F.J., Shafritz, A.B., Shortt, N.L., Siff, T., Spitler, C.A., Spoor, A.B., Streubel, P., Swiontkowski, M., Talbot, M., Taras, J.S., Tolo, E.T., Tyllianakis, M., van Demark, R.E., Jr., van der Heide, H., van der Plaat, L.W., van der Pluijm, M., van Eerten, P.V., Verbeek, D.O., Vochteloo, A.J., Walbeehm, R.P., Wascher, D.C., Wills, B.P.D., Wint, J., Zaidenberg, E.E., Zeltser, D.W., Crijns, Tom J., Merkel, Patrick, Kortlever, Joost T.P., Wagner, K. John, III, Ring, David, Vagner, Gregg, and Teunis, Teun
- Published
- 2022
- Full Text
- View/download PDF
5. Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada
- Author
-
Matthias Briel, Bernice S. Elger, Stuart McLennan, Stefan Schandelmaier, Erik von Elm, and Priya Satalkar
- Subjects
Randomized clinical trials ,Interview study ,Poor recruitment ,Reasons for recruitment failure ,Qualitative analysis ,Medicine (General) ,R5-920 - Abstract
Abstract Background Poor participant recruitment is the most frequent reason for premature discontinuation of randomized clinical trials (RCTs), particularly if they are investigator-initiated. The aims of this qualitative study were to investigate (1) the views of clinical trial stakeholders from three different countries regarding reasons for recruitment failure in RCTs and (2) how these compare and contrast with the causes identified in a previous systematic review of RCT publications. Methods From August 2015 to November 2016, we conducted 49 semi-structured interviews with a purposive sample of clinical trial stakeholders. This included investigators based in Germany (n = 9), Switzerland (n = 6) and Canada (n = 1) with personal experience of a discontinued RCT and 33 other stakeholders (e.g., representatives of ethics committees, clinical trial units, pharmaceutical industry) in Switzerland. Individual semi-structured qualitative interviews were conducted and analyzed using thematic analysis. Results Interviewees identified a total of 29 different reasons for recruitment failure. Overoptimistic recruitment estimates, too narrow eligibility criteria, lack of engagement of recruiters/trial team, lack of competence/training/experience of recruiters, insufficient initial funding, and high burden for trial participants were mentioned most frequently. The interview findings largely confirm the previous systematic review on published reasons for recruitment failure. However, eight new reasons for recruitment failure were identified in the interviews, which led to the checklist of reasons for recruitment failure being revised and a new category describing research environment-related factors being added. Conclusions This study highlights the diversity of often interlinked reasons for recruitment failure in RCTs. Integrating the findings of this interview study with a previous systematic review of RCT publications led to a comprehensive, structured checklist of empirically-informed reasons for recruitment failure. The checklist may be useful to guide further research on interventions to improve participant recruitment in RCTs and helpful for trial investigators, research ethics committees, and funding agencies when assessing trial feasibility with respect to recruitment.
- Published
- 2021
- Full Text
- View/download PDF
6. Library of Guidance for Health Scientists (LIGHTS): Eine neue Datenbank für methodische Leitlinien in der klinischen Forschung
- Author
-
Hirt, Julian, Ewald, Hannah, Briel, Matthias, and Schandelmaier, Stefan
- Subjects
database ,guidelines as topic ,methods ,methods guidance ,reporting quality ,transparency ,Bibliography. Library science. Information resources ,Medicine (General) ,R5-920 - Abstract
Methodological issues (e.g., ignoring missing data, irrelevant outcomes, flawed subgroup analyses) often limit the value of health research. One reason is that health researchers cannot easily find relevant methods guidance. To improve the findability of methods guidance, we initiated the development of the Library of Guidance for Health Scientists (LIGHTS, ). LIGHTS is a new open access database to effectively support health researchers, statisticians, methods consultants, methods developers, ethics boards, peer reviewers, journal editors, funding bodies, and others who are searching for optimal methods guidance in clinical research.
- Published
- 2022
- Full Text
- View/download PDF
7. Introducing Simulation-Based Learning for Trainees in Chronic Pain Medicine: Needs Assessment and Suggestions for Training Scenarios
- Author
-
Scheidecker, Anne, Green, Amanda, Syed, Muzammil H., Ling, Celine S., Fiala, Clare, Pakkal, Oya, Monteiro, Sandra, Schandelmaier, Stefan, and Korz, Linda
- Published
- 2021
- Full Text
- View/download PDF
8. Response Predictors of Repetitive Neuromuscular Magnetic Stimulation in the Preventive Treatment of Episodic Migraine
- Author
-
Corinna Börner, Tabea Renner, Florian Trepte-Freisleder, Giada Urban, Paul Schandelmaier, Magdalena Lang, Matthias F. Lechner, Helene Koenig, Birgit Klose, Lucia Albers, Sandro M. Krieg, Thomas Baum, Florian Heinen, Mirjam N. Landgraf, Nico Sollmann, and Michaela V. Bonfert
- Subjects
headache ,migraine ,neurostimulation ,non-invasive neuromodulation ,repetitive peripheral magnetic stimulation ,myofascial trigger point ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
BackgroundRepetitive neuromuscular magnetic stimulation (rNMS) of the trapezius muscles showed beneficial effects in preventing episodic migraine. However, clinical characteristics that predict a favorable response to rNMS are unknown. The objective of this analysis is to identify such predictors.MethodsThirty participants with a diagnosis of episodic migraine (mean age: 24.8 ± 4.0 years, 29 females), who were prospectively enrolled in two non-sham-controlled studies evaluating the effects of rNMS were analyzed. In these studies, the interventional stimulation of the bilateral trapezius muscles was applied in six sessions and distributed over two consecutive weeks. Baseline and follow-up assessments included the continuous documentation of a headache calendar over 30 days before and after the stimulation period, the Migraine Disability Assessment Score (MIDAS) questionnaire (before stimulation and 90 days after stimulation), and measurements of pain pressure thresholds (PPTs) above the trapezius muscles by algometry (before and after each stimulation session). Participants were classified as responders based on a ≥25% reduction in the variable of interest (headache frequency, headache intensity, days with analgesic intake, MIDAS score, left-sided PPTs, right-sided PPTs). Post-hoc univariate and multivariate binary logistic regression analyses were performed.ResultsLower headache frequency (P = 0.016) and intensity at baseline (P = 0.015) and a migraine diagnosis without a concurrent tension-type headache component (P = 0.011) were significantly related to a ≥25% reduction in headache frequency. Higher headache frequency (P = 0.052) and intensity at baseline (P = 0.014) were significantly associated with a ≥25% reduction in monthly days with analgesic intake. Lower right-sided PPTs at baseline were significantly related to a ≥25% increase in right-sided PPTs (P = 0.015) and left-sided PPTs (P =0.030). Performance of rNMS with higher stimulation intensities was significantly associated with a ≥25% reduction in headache intensity (P = 0.046).ConclusionsClinical headache characteristics at baseline, the level of muscular hyperalgesia, and stimulation intensity may inform about how well an individual patient responds to rNMS. These factors may allow an early identification of patients that would most likely benefit from rNMS.
- Published
- 2022
- Full Text
- View/download PDF
9. Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE)
- Author
-
Matthias Briel, Sally Hopewell, Arnav Agarwal, Joerg J Meerpohl, Jason W Busse, Patrick Hong, Matthias Schwenkglenks, Szimonetta Lohner, Benjamin Speich, Viktoria Gloy, Erik von Elm, Sirintip Sricharoenchai, Benjamin Kasenda, Stefan Schandelmaier, Dominik Mertz, Anette Blümle, Jacqueline Wong, Alain Amstutz, Belinda Von Niederhäusern, Alain Nordmann, Giusi Moffa, Dmitry Gryaznov, Elena Ojeda-Ruiz, Ayodele Odutayo, Yuki Tomonaga, Christiane Pauli-Magnus, Karin Bischoff, Katharina Wollmann, Laura Rehner, Katharina Klatte, Nilabh Ghosh, Ala Taji Heravi, Ngai Chow, Kimberly A McCord - De Iaco, Ramon Saccilotto, and Lars Hemkens
- Subjects
Medicine - Published
- 2022
- Full Text
- View/download PDF
10. Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding -- An Updated Meta-Analysis.
- Author
-
Ying Wang, Parpia, Sameer, Long Ge, Heels-Ansdell, Diane, Honghao Lai, Esfahani, Meisam Abdar, Bei Pan, Alhazzani, Waleed, Schandelmaier, Stefan, Lauzier, Francois, Arabi, Yaseen, Barletta, Jeffrey, Deane, Adam, Finfer, Simon, Williamson, David, Kanji, Salmaan, Møller, Morten H., Perner, Anders, Krag, Mette, and Young, Paul J.
- Subjects
PATIENT safety ,GASTROINTESTINAL hemorrhage ,PEPTIC ulcer ,TREATMENT effectiveness ,META-analysis ,SEVERITY of illness index ,RELATIVE medical risk ,PRE-exposure prophylaxis ,PROTON pump inhibitors ,CONFIDENCE intervals ,CRITICALLY ill patient psychology - Abstract
Background: The goal of this systematic review was to examine the efficacy and safety of proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients. Methods: We included randomized trials comparing proton-pump inhibitors versus placebo or no prophylaxis in critically ill adults, performed meta-analyses, and assessed certainty of evidence using the Grading of Recommendations, Assessment, Development, and Evaluations approach. To explore the effect of proton-pump inhibitors on mortality based on disease severity, a subgroup analysis was conducted combining within-trial subgroup data from the two largest trials and assessed credibility using the Instrument for Assessing the Credibility of Effect Modification Analyses. Results: Twelve trials that enrolled 9533 patients were included. Proton-pump inhibitors were associated with a reduced incidence of clinically important upper gastrointestinal bleeding (relative risk [RR], 0.51 [95% confidence interval (CI), 0.34 to 0.76]; high certainty evidence). Proton-pump inhibitors may have little or no effect on mortality (RR, 0.99 [95% CI, 0.93 to 1.05]; low certainty). Within-trial subgroup analysis with intermediate credibility suggested that the effect of proton-pump inhibitors on mortality may differ based on disease severity. Subgroup results raise the possibility that proton-pump inhibitors may decrease 90-day mortality in less severely ill patients (RR, 0.89; 95% CI, 0.80 to 0.98) and may increase mortality in more severely ill patients (RR, 1.08; 95% CI, 0.96 to 1.20]. Proton-pump inhibitors may have no effect on pneumonia and little or no effect on Clostridioides difficile infection (low certainty). Conclusions: High certainty evidence supports the association of proton-pump inhibitors with decreased upper gastrointestinal bleeding. Proton-pump inhibitors may have little or no effect on mortality, although a decrease in mortality in less severely ill patients and an increase in mortality in more severely ill patients remain possible. (PROSPERO number CRD42023461695.) [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis.
- Author
-
Benjamin Speich, Dmitry Gryaznov, Jason W Busse, Viktoria L Gloy, Szimonetta Lohner, Katharina Klatte, Ala Taji Heravi, Nilabh Ghosh, Hopin Lee, Anita Mansouri, Ioana R Marian, Ramon Saccilotto, Edris Nury, Benjamin Kasenda, Elena Ojeda-Ruiz, Stefan Schandelmaier, Yuki Tomonaga, Alain Amstutz, Christiane Pauli-Magnus, Karin Bischoff, Katharina Wollmann, Laura Rehner, Joerg J Meerpohl, Alain Nordmann, Jacqueline Wong, Ngai Chow, Patrick Jiho Hong, Kimberly Mc Cord-De Iaco, Sirintip Sricharoenchai, Arnav Agarwal, Matthias Schwenkglenks, Lars G Hemkens, Erik von Elm, Bethan Copsey, Alexandra N Griessbach, Christof Schönenberger, Dominik Mertz, Anette Blümle, Belinda von Niederhäusern, Sally Hopewell, Ayodele Odutayo, and Matthias Briel
- Subjects
Medicine - Abstract
BackgroundWe previously found that 25% of 1,017 randomized clinical trials (RCTs) approved between 2000 and 2003 were discontinued prematurely, and 44% remained unpublished at a median of 12 years follow-up. We aimed to assess a decade later (1) whether rates of completion and publication have increased; (2) the extent to which nonpublished RCTs can be identified in trial registries; and (3) the association between reporting quality of protocols and premature discontinuation or nonpublication of RCTs.Methods and findingsWe included 326 RCT protocols approved in 2012 by research ethics committees in Switzerland, the United Kingdom, Germany, and Canada in this metaresearch study. Pilot, feasibility, and phase 1 studies were excluded. We extracted trial characteristics from each study protocol and systematically searched for corresponding trial registration (if not reported in the protocol) and full text publications until February 2022. For trial registrations, we searched the (i) World Health Organization: International Clinical Trial Registry Platform (ICTRP); (ii) US National Library of Medicine (ClinicalTrials.gov); (iii) European Union Drug Regulating Authorities Clinical Trials Database (EUCTR); (iv) ISRCTN registry; and (v) Google. For full text publications, we searched PubMed, Google Scholar, and Scopus. We recorded whether RCTs were registered, discontinued (including reason for discontinuation), and published. The reporting quality of RCT protocols was assessed with the 33-item SPIRIT checklist. We used multivariable logistic regression to examine the association between the independent variables protocol reporting quality, planned sample size, type of control (placebo versus other), reporting of any recruitment projection, single-center versus multicenter trials, and industry versus investigator sponsoring, with the 2 dependent variables: (1) publication of RCT results; and (2) trial discontinuation due to poor recruitment. Of the 326 included trials, 19 (6%) were unregistered. Ninety-eight trials (30%) were discontinued prematurely, most often due to poor recruitment (37%; 36/98). One in 5 trials (21%; 70/326) remained unpublished at 10 years follow-up, and 21% of unpublished trials (15/70) were unregistered. Twenty-three of 147 investigator-sponsored trials (16%) reported their results in a trial registry in contrast to 150 of 179 industry-sponsored trials (84%). The median proportion of reported SPIRIT items in included RCT protocols was 69% (interquartile range 61% to 77%). We found no variables associated with trial discontinuation; however, lower reporting quality of trial protocols was associated with nonpublication (odds ratio, 0.71 for each 10% increment in the proportion of SPIRIT items met; 95% confidence interval, 0.55 to 0.92; p = 0.009). Study limitations include that the moderate sample size may have limited the ability of our regression models to identify significant associations.ConclusionsWe have observed that rates of premature trial discontinuation have not changed in the past decade. Nonpublication of RCTs has declined but remains common; 21% of unpublished trials could not be identified in registries. Only 16% of investigator-sponsored trials reported results in a trial registry. Higher reporting quality of RCT protocols was associated with publication of results. Further efforts from all stakeholders are needed to improve efficiency and transparency of clinical research.
- Published
- 2022
- Full Text
- View/download PDF
12. Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects
- Author
-
Dmitry Gryaznov, Ayodele Odutayo, Belinda von Niederhäusern, Benjamin Speich, Benjamin Kasenda, Elena Ojeda-Ruiz, Anette Blümle, Stefan Schandelmaier, Dominik Mertz, Yuki Tomonaga, Alain Amstutz, Christiane Pauli-Magnus, Viktoria Gloy, Karin Bischoff, Katharina Wollmann, Laura Rehner, Szimonetta Lohner, Joerg J. Meerpohl, Alain Nordmann, Katharina Klatte, Nilabh Ghosh, Ala Taji Heravi, Jacqueline Wong, Ngai Chow, Patrick Jiho Hong, Kimberly Mc Cord, Sirintip Sricharoenchai, Jason W. Busse, Arnav Agarwal, Ramon Saccilotto, Matthias Schwenkglenks, Giusi Moffa, Lars G. Hemkens, Sally Hopewell, Erik von Elm, and Matthias Briel
- Subjects
Randomized clinical trials ,Trial protocol ,Reporting quality ,Reporting guideline adherence ,Registration ,Trial discontinuation ,Medicine (General) ,R5-920 - Abstract
Abstract Background Clearly structured and comprehensive protocols are an essential component to ensure safety of participants, data validity, successful conduct, and credibility of results of randomized clinical trials (RCTs). Funding agencies, research ethics committees (RECs), regulatory agencies, medical journals, systematic reviewers, and other stakeholders rely on protocols to appraise the conduct and reporting of RCTs. In response to evidence of poor protocol quality, the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guideline was published in 2013 to improve the accuracy and completeness of clinical trial protocols. The impact of these recommendations on protocol completeness and associations between protocol completeness and successful RCT conduct and publication remain uncertain. Objectives and methods Aims of the Adherence to SPIrit REcommendations (ASPIRE) study are to investigate adherence to SPIRIT checklist items of RCT protocols approved by RECs in the UK, Switzerland, Germany, and Canada before (2012) and after (2016) the publication of the SPIRIT guidelines; determine protocol features associated with non-adherence to SPIRIT checklist items; and assess potential differences in adherence across countries. We assembled an international cohort of RCTs based on 450 protocols approved in 2012 and 402 protocols approved in 2016 by RECs in Switzerland, the UK, Germany, and Canada. We will extract data on RCT characteristics and adherence to SPIRIT for all included protocols. We will use multivariable regression models to investigate temporal changes in SPIRIT adherence, differences across countries, and associations between SPIRIT adherence of protocols with RCT registration, completion, and publication of results. We plan substudies to examine the registration, premature discontinuation, and non-publication of RCTs; the use of patient-reported outcomes in RCT protocols; SPIRIT adherence of RCT protocols with non-regulated interventions; the planning of RCT subgroup analyses; and the use of routinely collected data for RCTs. Discussion The ASPIRE study and associated substudies will provide important information on the impact of measures to improve the reporting of RCT protocols and on multiple aspects of RCT design, trial registration, premature discontinuation, and non-publication of RCTs observing potential changes over time.
- Published
- 2020
- Full Text
- View/download PDF
13. Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study
- Author
-
Benjamin Kasenda, Junhao Liu, Yu Jiang, Byron Gajewski, Cen Wu, Erik von Elm, Stefan Schandelmaier, Giusi Moffa, Sven Trelle, Andreas Michael Schmitt, Amanda K. Herbrand, Viktoria Gloy, Benjamin Speich, Sally Hopewell, Lars G. Hemkens, Constantin Sluka, Kris McGill, Maureen Meade, Deborah Cook, Francois Lamontagne, Jean-Marc Tréluyer, Anna-Bettina Haidich, John P. A. Ioannidis, Shaun Treweek, and Matthias Briel
- Subjects
Recruitment ,Accrual ,Prediction ,Randomized clinical trials ,Medicine (General) ,R5-920 - Abstract
Abstract Background Poor recruitment of patients is the predominant reason for early termination of randomized clinical trials (RCTs). Systematic empirical investigations and validation studies of existing recruitment models, however, are lacking. We aim to provide evidence-based guidance on how to predict and monitor recruitment of patients into RCTs. Our specific objectives are the following: (1) to establish a large sample of RCTs (target n = 300) with individual patient recruitment data from a large variety of RCTs, (2) to investigate participant recruitment patterns and study site recruitment patterns and their association with the overall recruitment process, (3) to investigate the validity of a freely available recruitment model, and (4) to develop a user-friendly tool to assist trial investigators in the planning and monitoring of the recruitment process. Methods Eligible RCTs need to have completed the recruitment process, used a parallel group design, and investigated any healthcare intervention where participants had the free choice to participate. To establish the planned sample of RCTs, we will use our contacts to national and international RCT networks, clinical trial units, and individual trial investigators. From included RCTs, we will collect patient-level information (date of randomization), site-level information (date of trial site activation), and trial-level information (target sample size). We will examine recruitment patterns using recruitment trajectories and stratifications by RCT characteristics. We will investigate associations of early recruitment patterns with overall recruitment by correlation and multivariable regression. To examine the validity of a freely available Bayesian prediction model, we will compare model predictions to collected empirical data of included RCTs. Finally, we will user-test any promising tool using qualitative methods for further tool improvement. Discussion This research will contribute to a better understanding of participant recruitment to RCTs, which could enhance efficiency and reduce the waste of resources in clinical research with a comprehensive, concerted, international effort.
- Published
- 2020
- Full Text
- View/download PDF
14. A systematic survey of randomised trials that stopped early for reasons of futility
- Author
-
S. D. Walter, H. Han, G. H. Guyatt, D. Bassler, N. Bhatnagar, V. Gloy, S. Schandelmaier, and M. Briel
- Subjects
Clinical trials ,interim analysis ,early stopping rules ,treatment effect size ,bias ,Medicine (General) ,R5-920 - Abstract
Abstract Background Randomised trial protocols may incorporate interim analyses, with the potential to stop the study for futility if early data show insufficient promise of a treatment benefit. Previously, we have shown that this approach will theoretically lead to mis-estimation of the treatment effect. We now wished to ascertain the importance of this phenomenon in practice. Methods We reviewed the methods and results in a set of trials that had stopped for futility, identified through an extensive literature search. We recorded clinical areas, interventions, study design, outcomes, trial setting, sponsorship, planned and actual treatment effects, sample sizes; power; and if there was a data safety monitoring board, or a published protocol. We identified: if interim analyses were pre-specified, and how many analyses actually occurred; what pre-specified criteria might define futility; if a futility analysis formed the basis for stopping; who made the decision to stop; and the conditional power of each study, i.e. the probability of statistically significant results if the study were to continue to its complete sample size. Results We identified 52 eligible trials, covering many clinical areas. Most trials had multiple centres, tested drugs, and 40% were industry sponsored. There were 75% where at least one interim analysis was planned a priori; a majority had only one interim analysis, typically with about half the target total sample size. A majority of trials did not pre-define a stopping rule, and a variety of reasons were given for stopping. Few studies calculated and reported low conditional power to justify the early stop. When conditional power could be calculated, it was typically low, especially under the current trend hypothesis. However, under the original design hypothesis, a few studies had relatively high conditional power. Data collection often continued after the interim analysis. Conclusions Although other factors will typically be involved, we conclude that, from the perspective of conditional power, stopping early for futility was probably reasonable in most cases, but documentation of the basis for stopping was often missing or vague. Interpretation of truncated trials would be enhanced by improved reporting of stopping protocols, and of their actual execution.
- Published
- 2020
- Full Text
- View/download PDF
15. Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada
- Author
-
Briel, Matthias, Elger, Bernice S., McLennan, Stuart, Schandelmaier, Stefan, von Elm, Erik, and Satalkar, Priya
- Published
- 2021
- Full Text
- View/download PDF
16. Migräne im Kindes- und Jugendalter – Ausblick auf innovative Behandlungsansätze im Rahmen multimodaler Therapiekonzepte
- Author
-
Bonfert, Michaela Veronika, Börner, Corinna, Gerstl, Lucia, Hannibal, Iris, Mathonia, Nina, Huß, Kristina, Rahmsdorf, Birte, Kainz, Christina, Klose, Birgit, Koenig, Helene, Urban, Giada, Schandelmaier, Paul, Renner, Tabea, Albers, Lucia, Krieg, Sandro Manuel, Sollmann, Nico, Heinen, Florian, and Landgraf, Mirjam Natascha
- Published
- 2020
- Full Text
- View/download PDF
17. Published patterns of spin in biomedical literature: a protocol for a meta-research study
- Author
-
Stefan Schandelmaier, Stefan Listl, Naichuan Su, Michiel van der Linden, Geert JMG van der Heijden, and Clovis M Faggion Jr
- Subjects
Medicine - Abstract
Introduction Spin is defined as reporting practices that distort the interpretation of results and create misleading conclusions by suggesting more favourable results. Such unjustifiable and misleading misrepresentation may negatively influence the development of further studies, clinical practice and healthcare policies. Spin manifests in various patterns in different sections of publications (titles, abstracts and main texts). The primary aim of this study is to identify reported spin patterns and assess the prevalence of spin in general, and the prevalence of spin patterns reported in biomedical literature based on previously published systematic reviews and literature reviews on spin.Methods and analysis PubMed, EMBASE and SCOPUS will be searched to identify systematic or literature reviews on spin in biomedicine. To improve the comprehensiveness of the search, the snowballing method will be used to broaden the search. The data on spin-related outcomes and characteristics of the included studies will be extracted. The methodological quality of the included studies will be assessed with selective items of the A MeaSurement Tool to Assess systematic Reviews-2 checklist. A new classification scheme for spin patterns will be developed if the classifications of spin patterns identified in the included studies vary. The prevalence of spin and spin patterns will be pooled based on meta-analyses if the classification schemes for spin are comparable across included studies. Otherwise, the prevalence will be described qualitatively. The seriousness of spin patterns will be assessed based on a Delphi consensus study.Ethics and dissemination This study has been approved by the Academic Centre for Dentistry Amsterdam Ethics Review Committee (2020250). The study will be submitted to a peer-reviewed scientific journal.Registration Open Science Framework: osf.io/hzv6e
- Published
- 2021
- Full Text
- View/download PDF
18. Reporting of methodological studies in health research: a protocol for the development of the MethodologIcal STudy reportIng Checklist (MISTIC)
- Author
-
Matthias Briel, Stefan Schandelmaier, Anders K Nørskov, and David B Allison
- Subjects
Medicine - Abstract
Introduction Methodological studies (ie, studies that evaluate the design, conduct, analysis or reporting of other studies in health research) address various facets of health research including, for instance, data collection techniques, differences in approaches to analyses, reporting quality, adherence to guidelines or publication bias. As a result, methodological studies can help to identify knowledge gaps in the methodology of health research and strategies for improvement in research practices. Differences in methodological study names and a lack of reporting guidance contribute to lack of comparability across studies and difficulties in identifying relevant previous methodological studies. This paper outlines the methods we will use to develop an evidence-based tool—the MethodologIcal STudy reportIng Checklist—to harmonise naming conventions and improve the reporting of methodological studies.Methods and analysis We will search for methodological studies in the Cumulative Index to Nursing and Allied Health Literature, Cochrane Library, Embase, MEDLINE, Web of Science, check reference lists and contact experts in the field. We will extract and summarise data on the study names, design and reporting features of the included methodological studies. Consensus on study terms and recommended reporting items will be achieved via video conference meetings with a panel of experts including researchers who have published methodological studies.Ethics and dissemination The consensus study has been exempt from ethics review by the Hamilton Integrated Research Ethics Board. The results of the review and the reporting guideline will be disseminated in stakeholder meetings, conferences, peer-reviewed publications, in requests to journal editors (to endorse or make the guideline a requirement for authors), and on the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network and reporting guideline websites.Registration We have registered the development of the reporting guideline with the EQUATOR Network and publicly posted this project on the Open Science Framework (www.osf.io/9hgbq).
- Published
- 2020
- Full Text
- View/download PDF
19. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days [version 2; peer review: 2 approved]
- Author
-
Perrine Janiaud, Cathrine Axfors, Janneke van't Hooft, Ramon Saccilotto, Arnav Agarwal, Christian Appenzeller-Herzog, Despina G. Contopoulos-Ioannidis, Valentin Danchev, Ulrich Dirnagl, Hannah Ewald, Gerald Gartlehner, Steven N. Goodman, Noah A. Haber, Angeliki Diotima Ioannidis, John P. A. Ioannidis, Mark P. Lythgoe, Wenyan Ma, Malcolm Macleod, Mario Malički, Joerg J. Meerpohl, Yan Min, David Moher, Blin Nagavci, Florian Naudet, Christiane Pauli-Magnus, Jack W. O'Sullivan, Nico Riedel, Jan A. Roth, Mandy Sauermann, Stefan Schandelmaier, Andreas M. Schmitt, Benjamin Speich, Paula R. Williamson, and Lars G. Hemkens
- Subjects
Medicine ,Science - Abstract
Background: Never before have clinical trials drawn as much public attention as those testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical research response and its evolution over the first 100 days of the pandemic. Methods: Descriptive analysis of planned, ongoing or completed trials by April 9, 2020 testing any intervention to treat or prevent COVID-19, systematically identified in trial registries, preprint servers, and literature databases. A survey was conducted of all trials to assess their recruitment status up to July 6, 2020. Results: Most of the 689 trials (overall target sample size 396,366) were small (median sample size 120; interquartile range [IQR] 60-300) but randomized (75.8%; n=522) and were often conducted in China (51.1%; n=352) or the USA (11%; n=76). 525 trials (76.2%) planned to include 155,571 hospitalized patients, and 25 (3.6%) planned to include 96,821 health-care workers. Treatments were evaluated in 607 trials (88.1%), frequently antivirals (n=144) or antimalarials (n=112); 78 trials (11.3%) focused on prevention, including 14 vaccine trials. No trial investigated social distancing. Interventions tested in 11 trials with >5,000 participants were also tested in 169 smaller trials (median sample size 273; IQR 90-700). Hydroxychloroquine alone was investigated in 110 trials. While 414 trials (60.0%) expected completion in 2020, only 35 trials (4.1%; 3,071 participants) were completed by July 6. Of 112 trials with detailed recruitment information, 55 had recruited
- Published
- 2020
- Full Text
- View/download PDF
20. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days [version 1; peer review: 2 approved]
- Author
-
Perrine Janiaud, Cathrine Axfors, Janneke van't Hooft, Ramon Saccilotto, Arnav Agarwal, Christian Appenzeller-Herzog, Despina G. Contopoulos-Ioannidis, Valentin Danchev, Ulrich Dirnagl, Hannah Ewald, Gerald Gartlehner, Steven N. Goodman, Noah A. Haber, Angeliki Diotima Ioannidis, John P. A. Ioannidis, Mark P. Lythgoe, Wenyan Ma, Malcolm Macleod, Mario Malički, Joerg J. Meerpohl, Yan Min, David Moher, Blin Nagavci, Florian Naudet, Christiane Pauli-Magnus, Jack W. O'Sullivan, Nico Riedel, Jan A. Roth, Mandy Sauermann, Stefan Schandelmaier, Andreas M. Schmitt, Benjamin Speich, Paula R. Williamson, and Lars G. Hemkens
- Subjects
Medicine ,Science - Abstract
Background: Never before have clinical trials drawn as much public attention as those testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical research response and its evolution over the first 100 days of the pandemic. Methods: Descriptive analysis of planned, ongoing or completed trials by April 9, 2020 testing any intervention to treat or prevent COVID-19, systematically identified in trial registries, preprint servers, and literature databases. A survey was conducted of all trials to assess their recruitment status up to July 6, 2020. Results: Most of the 689 trials (overall target sample size 396,366) were small (median sample size 120; interquartile range [IQR] 60-300) but randomized (75.8%; n=522) and were often conducted in China (51.1%; n=352) or the USA (11%; n=76). 525 trials (76.2%) planned to include 155,571 hospitalized patients, and 25 (3.6%) planned to include 96,821 health-care workers. Treatments were evaluated in 607 trials (88.1%), frequently antivirals (n=144) or antimalarials (n=112); 78 trials (11.3%) focused on prevention, including 14 vaccine trials. No trial investigated social distancing. Interventions tested in 11 trials with >5,000 participants were also tested in 169 smaller trials (median sample size 273; IQR 90-700). Hydroxychloroquine alone was investigated in 110 trials. While 414 trials (60.0%) expected completion in 2020, only 35 trials (4.1%; 3,071 participants) were completed by July 6. Of 112 trials with detailed recruitment information, 55 had recruited
- Published
- 2020
- Full Text
- View/download PDF
21. Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects
- Author
-
Gryaznov, Dmitry, Odutayo, Ayodele, von Niederhäusern, Belinda, Speich, Benjamin, Kasenda, Benjamin, Ojeda-Ruiz, Elena, Blümle, Anette, Schandelmaier, Stefan, Mertz, Dominik, Tomonaga, Yuki, Amstutz, Alain, Pauli-Magnus, Christiane, Gloy, Viktoria, Bischoff, Karin, Wollmann, Katharina, Rehner, Laura, Lohner, Szimonetta, Meerpohl, Joerg J., Nordmann, Alain, Klatte, Katharina, Ghosh, Nilabh, Heravi, Ala Taji, Wong, Jacqueline, Chow, Ngai, Hong, Patrick Jiho, Cord, Kimberly Mc, Sricharoenchai, Sirintip, Busse, Jason W., Agarwal, Arnav, Saccilotto, Ramon, Schwenkglenks, Matthias, Moffa, Giusi, Hemkens, Lars G., Hopewell, Sally, von Elm, Erik, and Briel, Matthias
- Published
- 2020
- Full Text
- View/download PDF
22. Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study
- Author
-
Kasenda, Benjamin, Liu, Junhao, Jiang, Yu, Gajewski, Byron, Wu, Cen, von Elm, Erik, Schandelmaier, Stefan, Moffa, Giusi, Trelle, Sven, Schmitt, Andreas Michael, Herbrand, Amanda K., Gloy, Viktoria, Speich, Benjamin, Hopewell, Sally, Hemkens, Lars G., Sluka, Constantin, McGill, Kris, Meade, Maureen, Cook, Deborah, Lamontagne, Francois, Tréluyer, Jean-Marc, Haidich, Anna-Bettina, Ioannidis, John P. A., Treweek, Shaun, and Briel, Matthias
- Published
- 2020
- Full Text
- View/download PDF
23. A systematic survey of randomised trials that stopped early for reasons of futility
- Author
-
Walter, S. D., Han, H., Guyatt, G. H., Bassler, D., Bhatnagar, N., Gloy, V., Schandelmaier, S., and Briel, M.
- Published
- 2020
- Full Text
- View/download PDF
24. Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation.
- Author
-
Benjamin Speich, Nadine Schur, Dmitry Gryaznov, Belinda von Niederhäusern, Lars G Hemkens, Stefan Schandelmaier, Alain Amstutz, Benjamin Kasenda, Christiane Pauli-Magnus, Elena Ojeda-Ruiz, Yuki Tomonaga, Kimberly McCord, Alain Nordmann, Erik von Elm, Matthias Briel, Matthias Schwenkglenks, and a collaboration of the MARTA (MAking Randomized Trials Affordable) and ASPIRE (Adherence to Standard Protocol Items: REcommendations for interventional trials) Study Groups
- Subjects
Medicine ,Science - Abstract
BackgroundThe preparation of a randomized controlled trial (RCT) requires substantial resources and the administrative processes can be burdensome. To facilitate the conduct of RCTs it is important to better understand cost drivers. In January 2014 the enactment of the new Swiss Legislation on Human Research (LHR) considerably changed the regulatory framework in Switzerland. We assess if the new LHR was associated with change in (i) resource use and costs to prepare an RCT, and (ii) approval times with research ethics committees (RECs) and the regulatory authority Swissmedic.MethodsWe surveyed investigators of RCTs which were approved by RECs in 2012 or in 2016 and asked for RCT preparation costs using a pre-specified item list. Additionally, we collected approval times from RECs and Swissmedic.ResultsThe response rates of the investigator survey were 8.3% (19/228) for 2012 and 16.5% (47/285) in 2016. The median preparation cost of an RCT was USD 72,400 (interquartile range [IQR]: USD 59,500-87,700; n = 18) in 2012 and USD 72,600 (IQR: USD 42,800-169,600; n = 35) in 2016. For single centre RCTs a median REC approval time of 82 (IQR: 49-107; n = 38) days in 2012 and 92 (IQR: 65-131; n = 63) days in 2016 was observed. The median Swissmedic approval time for any clinical trial was 27 (IQR: 19-51; n = 213) days in 2012 and 49 (IQR: 36-67; n = 179) days in 2016. The total duration for achieving RCT approval from both authorities (REC and Swissmedic) in the parallel submission procedure applied in 2016 could not be assessed.ConclusionBased on limited data the costs to plan and prepare RCTs in Switzerland were approximately USD 72,000 in 2012 and 2016. For effective and valid research on costs and approval times of RCTs a greater willingness to share cost information among investigators and more collaboration between stakeholders with data linkage is necessary.
- Published
- 2019
- Full Text
- View/download PDF
25. Interpretation of Post-operative Distal Humerus Radiographs After Internal Fixation: Prediction of Later Loss of Fixation
- Author
-
Spoor, A.B., Chauhan, A., Wahegaonkar, A.L., Shafritz, A.B., Garcia G, A.E., Miller, A.N., Barquet, A., Kristan, A., Apard, T., Armstrong, A.D., Berner, A., Jubel, A., Kreis, B.E., Babis, C.G., Sutker, B., Sears, B.W., Nolan, B.M., Crist, B.D., Cross, B.J., Wills, B.P., Barreto, C.J., Ekholm, C., Swigart, C., Oliveira Miranda, C.D., Manke, C., Zalavras, C., Goldfarb, C.A., Cassidy, C., Walsh, C.J., Jones, C.M., Garnavos, C., Young, C., Moreno-Serrano, C.L., Lomita, C., Klostermann, C., van Deurzen, D.F., Rikli, D.A., Polatsch, D., Beingessner, D., Drosdowech, D., Eygendaal, D., Patel, M., Brilej, D., Walbeehm, E.T., Ballas, E.G., Ibrahim, E.F., Melamed, E., Stojkovska Pemovska, E., Hofmeister, E., Hammerberg, E.M., Kaplan, F.T., Suarez, F., Fernandes, C.H., Lopez-Gonzalez, F., Walter, F.L., Frihagen, F., Kraan, G.A., Kontakis, G., Dyer, G.S., Kohut, G., Panagopoulos, G., Hernandez, G.R., Porcellini, G., Bayne, G.J., Merrell, G., DeSilva, G., Della Rocca, G.J., Bamberger, H.B., Broekhuyse, H., Durchholz, H., Kodde, I.F., McGraw, I., Harris, I., Pountos, I., Wiater, J.M., Choueka, J., Kazanjian, J.E., Gillespie, J.A., Biert, J., Fanuele, J.C., Johnson, J.W., Greenberg, J.A., Abrams, J., Hall, J., Fischer, J., Scheer, J.H., Itamura, J., Capo, J.T., Braman, J., Rubio, J., Ortiz, J.A., Filho, J.E., Nolla, J., Abboud, J., Conflitti, J.M., Abzug, J.M., Patiño, J.M., Rodríguez Roiz, J.M., Adams, J., Bishop, J., Kabir, K., Chivers, K., Prommersberger, K., Egol, K., Rumball, K.M., Dickson, K., Jeray, K., Poelhekke, L.M., Campinhos, L.A., Mica, L., Borris, L.C., Adolfsson, L.E., Schulte, L.M., Elmans, L., Lane, L.B., Paz, L., Taitsman, L., Guenter, L., Austin, L.S., Waseem, M., Palmer, M.J., Abdel-Ghany, M.I., Richard, M.J., Rizzo, M., Pirpiris, M., Di Micoli, M., Bonczar, M., Loebenberg, M.I., Richardson, M., Mormino, M., Menon, M., Soong, M., Wood, M.M., Meylaerts, S.A., Darowish, M., Nancollas, M., Prayson, M., Grafe, M.W., Kessler, M.W., Kaminaris, M.D., Pirela-Cruz, M.A., Mckee, M., Merchant, M., Tyllianakis, M., Shafi, M., Powell, A.J., Shortt, N.L., Felipe, N.E., Parnes, N., Bijlani, N., Elias, N., Akabudike, N.M., Rossiter, N., Lasanianos, N.G., Kanakaris, N.K., Brink, O., van Eerten, P.V., Paladini, P., Martineau, P.A., Appleton, P., Levin, P., Althausen, P., Evans, P.J., Jebson, P., Krause, P., Schandelmaier, P., Peters, A., Dantuluri, P., Blazar, P., Andreas, P., Inna, P., Quell, M., Ramli, R.M., de Bedout, R., Ranade, A.B., Ashish, S., Smith, R.M., Babst, R.H., Omid, R., Buckley, R., Jenkinson, R., Gilbert, R.S., Page, R.S., Papandrea, R., Zura, R.D., Gray, R.L, Wagenmakers, R., Pesantez, R., van Riet, R., Calfee, R.P., van Helden, S.H., Bouaicha, S., Kakar, S., Kaplan, S., Scott, F.D., Kaar, S.G., Mitchell, S., Rowinski, S., Dodds, S., Kennedy, S.A., Beldner, S., Schepers, T., Guitton, T.G., Gosens, T., Baxamusa, T., Taleb, C., Tosounidis, T., Wyrick, T., Begue, T., DeCoster, T., Dienstknecht, T., Varecka, T.F., Mittlmeier, T., Fischer, T.J., Chesser, T., Omara, T., Bafus, T., Siff, T., Havlicek, T., Sabesan, V.J., Nikolaou, V.S., Philippe, V., Giordano, V., Vochteloo, A.J., Batson, W.A., Hammert, W.C., Satora, W., Weil, Y., Ruch, D., Marsh, L., Swiontkowski, M., Hurwit, S., Claessen, Femke M.A.P., Stoop, Nicky, Doornberg, Job N., Guitton, Thierry G., van den Bekerom, Michel P.J., and Ring, David
- Published
- 2016
- Full Text
- View/download PDF
26. The Interobserver Reliability of Grading of Distal Radius Volar Plate Prominence
- Author
-
Crijns, Tom J., primary, Merkel, Patrick, additional, Kortlever, Joost T.P., additional, Wagner, K. John, additional, Ring, David, additional, Vagner, Gregg, additional, Teunis, Teun, additional, Akabudike, N.M., additional, Apard, T., additional, Bafus, B.T., additional, Ballas, E.G., additional, Bamberger, H.B., additional, Baxamusa, T., additional, Begue, T.C., additional, Belangero, W.D., additional, Benhaim, P., additional, Biert, J., additional, Blazar, P., additional, Bloemers, F.W., additional, Borris, L.C., additional, Brink, O., additional, Brubacher, J.W., additional, Buckley, R., additional, Calcagni, M., additional, Calfee, R.P., additional, Campbell, S.T., additional, Chepla, K.J., additional, Choudhari, P., additional, Conflitti, J.M., additional, Coomber, R., additional, de Bedout, R., additional, Debeij, J., additional, DeCoster, T., additional, DeSilva, G., additional, Domenech, J., additional, Draeger, R.W., additional, Dwyer, C.L., additional, Elias, N., additional, Erickson, J.M., additional, Evans, P.J., additional, Farr, S., additional, Fernandes, C.H., additional, Fricker, R., additional, Garnavos, C., additional, Gilbert, R.S., additional, Giordano, V., additional, Goost, H., additional, Gosens, T., additional, Guitton, T.G., additional, Hammert, W.C., additional, Havlicek, T., additional, Hearon, B.F., additional, Henry, S.L., additional, Hobby, J.L., additional, Hodel, S., additional, Hofmeister, E.P., additional, Huang, J.I., additional, Jebson, P., additional, Jenkinson, R., additional, Jeray, K., additional, Kabir, K., additional, Kanakaris, N.K., additional, Kaplan, F.T.D., additional, Kennedy, S.A., additional, Klostermann, C., additional, Knobe, M., additional, Kraan, G.A., additional, Kristan, A., additional, Lane, L.B., additional, Lawson McLean, A., additional, Lightdale-Miric, N., additional, Metzger, C.L., additional, Mica, L., additional, Miranda, G.V., additional, Mirck, B., additional, Mitchell, S., additional, Mittlmeier, T., additional, Moreno-Serrano, C.L., additional, Nancollas, M.P., additional, Ortiz, J.A., additional, Peters, A., additional, Pianka, G., additional, Pirpiris, M., additional, Poelhekke, L.M.S.J., additional, Prkic, A., additional, Prommersberger, K.J., additional, Raven, E.E.J., additional, Rizzo, M., additional, Rodner, C., additional, Rodríguez Roiz, J.M., additional, Rohde, R.S., additional, Romero, C.J., additional, Sandoval, J., additional, Schandelmaier, P., additional, Schep, N.W.L., additional, Schepers, T., additional, Schiffer, G., additional, Seibert, F.J., additional, Shafritz, A.B., additional, Shortt, N.L., additional, Siff, T., additional, Spitler, C.A., additional, Spoor, A.B., additional, Streubel, P., additional, Swiontkowski, M., additional, Talbot, M., additional, Taras, J.S., additional, Tolo, E.T., additional, Tyllianakis, M., additional, van Demark, R.E., additional, van der Heide, H., additional, van der Plaat, L.W., additional, van der Pluijm, M., additional, van Eerten, P.V., additional, Verbeek, D.O., additional, Vochteloo, A.J., additional, Walbeehm, R.P., additional, Wascher, D.C., additional, Wills, B.P.D., additional, Wint, J., additional, Zaidenberg, E.E., additional, and Zeltser, D.W., additional
- Published
- 2022
- Full Text
- View/download PDF
27. Online Studies on Variation in Orthopedic Surgery: Computed Tomography in MPEG4 Versus DICOM Format
- Author
-
Mellema, Jos J., Mallee, Wouter H., Guitton, Thierry G., van Dijk, C. Niek, Ring, David, Doornberg, Job N., Babis, G. C., Jeray, K. J., Prayson, M. J., Pesantez, R., Acacio, R., Verbeek, D. O., Melvanki, P., Kreis, B. E., Mehta, S., Meylaerts, S., Wojtek, S., Yeap, E. J., Haapasalo, H., Kristan, A., Coles, C., Marsh, J. L., Mormino, M., Menon, M., Tyllianakis, M., Schandelmaier, P., Jenkinson, R. J., Neuhaus, V., Shahriar, C. M. H., Belangero, W. D., Kannan, S. G., Leonidovich, G. M., Davenport, J. H., Kabir, K., Althausen, P. L., Weil, Y., Toom, A., Sa da Costa, D., Lijoi, F., Koukoulias, N. E., Manidakis, N., Van den Bogaert, M., Patczai, B., Grauls, A., Kurup, H., van den Bekerom, M. P., Lansdaal, J. R., Vale, M., Ousema, P., Barquet, A., Cross, B. J., Broekhuyse, H., Haverkamp, D., Merchant, M., Harvey, E., Pemovska, E. Stojkovska, Frihagen, F., Seibert, F. J., Garnavos, C., van der Heide, H., Villamizar, H. A., Harris, I., Borris, L. C., Brink, O., Brink, P. R. G., Choudhari, P., Swiontkowski, M., Mittlmeier, T., Tosounidis, T., van Rensen, I., Martinelli, N., Park, D. H., Lasanianos, N., Vide, J., Engvall, A., Zura, R. D., Jubel, A., Kawaguchi, A., Goost, H., Bishop, J., Mica, L., Pirpiris, M., van Helden, S. H., Bouaicha, S., Schepers, T., Havliček, T., Giordano, V., and Science of Variation Group & Traumaplatform Study Collaborative
- Published
- 2017
- Full Text
- View/download PDF
28. Tumor Infiltrating Lymphocytes in Pet Rabbit Mammary Carcinomas: A Study with Relevance to Comparative Pathology
- Author
-
Sandra Schöniger, Sophie Degner, Qian Zhang, Claudia Schandelmaier, Heike Aupperle-Lellbach, Bharat Jasani, and Heinz-Adolf Schoon
- Subjects
animal model ,biomarker ,breast cancer ,comparative pathology ,mammary carcinomas ,light microscopy ,Veterinary medicine ,SF600-1100 ,Zoology ,QL1-991 - Abstract
Tumor infiltrating lymphocytes (TILs) serve as prognostic biomarker in human breast cancer. Rabbits have the potential to act as animal model for human breast cancer, and close similarities exist between the rabbit and human immune system. The aim of this study is to characterize TILs in pet rabbit mammary carcinomas and to statistically correlate results with histological and immunohistochemical tumor characteristics. Microscopic evaluation of TILs was performed in hematoxylin and eosin stained sections of 107 rabbit mammary carcinomas according to international guidelines for human breast cancer. Data on histological features of malignancy, estrogen and progesterone receptor status and calponin expression were obtained from the data base. This study revealed a statistical association between stromal TILs in the central tumor (CT) and infiltrative margin. Higher maximal percentages of stromal TILs at the CT were statistically correlated with decreased mitotic count and lower tumor grade. An increased number of calponin positive tumor cells was statistically associated with a lower mitotic count and a higher percentage of stromal TILs. Results suggest that higher percentages of stromal TILs are useful biomarkers that may point toward a favorable prognosis in rabbit mammary carcinomas and support the concept of the use of rabbits for translational research.
- Published
- 2020
- Full Text
- View/download PDF
29. Funding characteristics of randomised clinical trials supported by the Swiss National Science Foundation: a retrospective cohort study
- Author
-
Alain Amstutz, Stefan Schandelmaier, Roy Frei, Jakub Surina, Arnav Agarwal, Reem Alturki, Belinda von Niederhäusern, Erik von Elm, Matthias Briel, and on behalf of the MAking Randomized Trials Affordable (MARTA) Group
- Subjects
randomised clinical trials ,clinical trial costs ,early termination of clinical trials ,non-publication ,Swiss National Science Foundation ,Medicine - Abstract
AIMS OF THE STUDY Failure to publish publicly funded research represents a waste of scarce research resources across medical disciplines and countries. In Switzerland, about 40% of randomised clinical trials (RCTs) supported by the Swiss National Science Foundation (SNSF) were not published. We aimed to describe funding characteristics of published and unpublished RCTs supported by the SNSF, to quantify the amount of money spent for unpublished studies, and to compare our results to a similar study performed in the UK. METHODS We established a retrospective cohort of RCTs funded by the SNSF up to 2015. For each RCT proposal, two investigators independently identified corresponding publications in electronic databases and trial registries. Teams of two investigators independently extracted details from the original SNSF proposal and, if available, from trial registries or publications. In addition, we surveyed principal investigators about trial costs and additional sources of funding. RESULTS We included 101 RCTs supported by the SNSF between 1986 and 2015. Most were single-centre RCTs with a median of 138 participants (interquartile range [IQR] 76–400). Overall, 67 (67%) principal investigators responded to our main survey questions. Median total costs per RCT were CHF 428 000 (IQR 282 000–900 000) of which the SNSF provided a median CHF 222 000 (67% of total costs, IQR 40–80%). Most investigators (70%) mentioned additional funding, mainly from their own institution or private foundations. A total of CHF 6.7 million was granted to RCTs that remained unpublished. Funding characteristics were similar to publicly funded trials in the UK. CONCLUSIONS A third of the total SNSF grant sum spent on healthcare RCTs between 1986 and 2015 did not result in peer-reviewed scientific publications. New SNSF grant schemes might improve publication outcomes but their effectiveness needs to be evaluated.
- Published
- 2018
- Full Text
- View/download PDF
30. Interobserver Variability in the Treatment of Little Finger Metacarpal Neck Fractures
- Author
-
Spoor, A.B., Shafritz, A.B., Platz, A., Berner, A., Terrono, A.L., Jubel, A., Kreis, B.E., Hearon, B.F., Bottke, C.A., Broekhuyse, H., Buckley, R., Watkins, B., Fernandes, C.H., Metzger, C., Taleb, C., Bainbridge, L.C., Cornell, C., van Deurzen, D.F.P., Osei, D.A., Haverkamp, D., Oloruntoba, D.O., Eygendaal, D., Verbeek, D.O.F., Kalainov, D.M., Polatsch, D., Melvanki, P., Shafi, M., van Riet, R., Ruchelsman, D., Duncan, S.F., Pemovska, E. Stojkovska, Tolo, E.T., Schumer, E.D., Frihagen, F., Raia, F.J., DeSilva, G., Dyer, G.S.M., Frykman, G.K., Kontakis, G., Gaston, R., Garrigues, G., Hernandez, G.R., Grunwald, H.W., Balfour, G.W., Nancollas, M., Young, C., Pess, G.M., Durchholz, H., Erol, K., Biert, J., Choueka, J., Wolf, J.M., Doornberg, J.N., Ponsen, K.J., Kakar, S., Eng, K., Jeray, K., Lee, K., Rumball, K.M., Kabir, K., Kraan, G.A., Poelhekke, L.M.S.J., Ladislav, M., Weiss, L., Borris, L.C., Paz, L., Mormino, M., Bonczar, M., Hammerberg, E.M., Kastelec, M., Calcagni, M., Mazzocca, A.D., Darowish, M., Costanzo, R.M., Abdel-Ghany, M.I., Baskies, M., Patel, M., Prayson, M., Tyllianakis, M., Elias, N., Shortt, N.L., Leung, N.L., Kanakaris, N.K., Omid, R., Forigua Jaime, E., Brink, P.R.G., Kloen, P., Van Eerten, P.V., Lygdas, P., Benhaim, P., García, F., Guenter, L., Haverlag, R., Liem, R., Smith, R.M., Page, R.S., Schmidt, A., Mitchell, S., Dodds, S., Nolan, B.M., Moghtaderi, S., Siff, T., Begue, T., Hughes, T., Stackhouse, T.G., Tosounidis, T., Philippe, V., Wall, C.J., Hammert, W.C., Weil, Y., Satora, W., Fischer, J., van der Zwan, A.L., Adams, J., Garcia, A.E., Vochteloo, A.J.H., Barquet, A., Kristan, A., Bamberger, H.B., van den Bekerom, M.P.J., Belangero, W.D., Benjamin, W.T., Walter, F.L., Boyer, M., Wills, B.P.D., Calfee, R.P., Ekholm, C., Swigart, C., Cassidy, C., Oliveira Miranda, C.D., Wilson, C.J., Moreta-Suarez, J., Wilson, C., Moreno-Serrano, C.L., Manke, C., Jones, C.M., Klostermann, C., Della Rocca, G.J., Barreto, C.J., Merchant, M., Brilej, D., Bijlani, N., Silva, D.M., Harvey, E., Walbeehm, E.T., Suarez, F., Lopez-Gonzalez, F., Caro, G.C., Garnavos, C., Athwal, G.S., Babis, G.C., Kohut, G., Gradl, G., Huemer, G.M., Goldfarb, C.A., Bayne, G.J., Campinhos, L.A.B., Gutow, A.P., Marczyk, S.C., Lane, L.B., Goost, H., Villamizar, H.A., Hofmeister, E., McGraw, I., Goslings, J.C., Di Giovanni, J.F., Abzug, J.M., McAuliffe, J., Isaacs, J., Itamura, J., Conflitti, J.M., Munyak, J., Nolla, J., Scheer, J.H., Erickson, J.M., Wint, J., Chivers, K., Kirkpatrick, D.K., Malone, K.J., Dickson, K., Adolfsson, L.E., Van de Sande, M.A.J., Richard, M.J., Menon, M., Soong, M., Wood, M.M., Quell, M., Behrman, M., Kessler, M.W., Palmer, M.J., Pirpiris, M., Grafe, M.W., Schep, N., Nelson, D.L., Wilson, N., Capo, J.T., Calandruccio, J., Semenkin, O.M., Veillette, C.J.H., Richardson, M., Inna, P., Althausen, P., Martineau, P.A., Blazar, P., Hahn, P., Schandelmaier, P., Guidera, P., Jebson, P., Batson, W.A., de Bedout, R., Shatford, R., Rowinski, S., Fricker, R.M., Hauck, R., Wallensten, R., Papandrea, R., Gilbert, R.S., Rizzo, M., Hutchison, R.L., Zura, R.D., Cardoso, R., Pesantez, R., Spruijt, S., Kennedy, S.A., Mehta, S., Beldner, S., Kaplan, S., Kaar, S.G., Meylaerts, S.A., Streubel, P.N., Omara, T., Swiontkowski, M., Gosens, T., DeCoster, T., Baxamusa, T., Dienstknecht, T., Kaplan, F.T.D., Higgins, T., Mittlmeier, T., Apard, T., Fischer, T.J., Havliček, T., Wyrick, T., Giordano, V., Neuhaus, V., Nikolaou, V.S., Wright, T., Zalavras, C., Tosti, Rick, Ilyas, Asif M., Mellema, Jos J., Guitton, Thierry G., and Ring, David
- Published
- 2014
- Full Text
- View/download PDF
31. Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research quality.
- Author
-
Belinda von Niederhäusern, Stefan Schandelmaier, Marie Mi Bonde, Nicole Brunner, Lars G Hemkens, Marielle Rutquist, Neera Bhatnagar, Gordon H Guyatt, Christiane Pauli-Magnus, and Matthias Briel
- Subjects
Medicine ,Science - Abstract
OBJECTIVE:To systematically survey existing definitions, concepts, and criteria of clinical research quality, both developed by stakeholder groups as well as in the medical literature. This study serves as a first step in the development of a comprehensive framework for the quality of clinical research. STUDY DESIGN AND SETTING:We systematically and in duplicate searched definitions, concepts and criteria of clinical research quality on websites of stakeholders in clinical research until no further insights emerged and in MEDLINE up to February 2015. Stakeholders included governmental bodies, regulatory agencies, the pharmaceutical industry, academic and commercial contract research organizations, initiatives, research ethics committees, patient organizations and funding agencies from 13 countries. Data synthesis involved descriptive and qualitative analyses following the Framework Method on definitions, concepts, and criteria of clinical research quality. Descriptive codes were applied and grouped into clusters to identify common and stakeholder-specific quality themes. RESULTS:Stakeholder concepts on how to assure quality throughout study conduct or articles on quality assessment tools were common, generally with no a priori definition of the term quality itself. We identified a total of 20 explicit definitions of clinical research quality including varying quality dimensions and focusing on different stages in the clinical research process. Encountered quality dimensions include ethical conduct, patient safety/rights/priorities, internal validity, precision of results, generalizability or external validity, scientific and societal relevance, transparency and accessibility of information, research infrastructure and sustainability. None of the definitions appeared to be comprehensive either in terms of quality dimensions, research stages, or stakeholder perspectives. CONCLUSION:Clinical research quality is often discussed but rarely defined. A framework defining clinical research quality across stakeholders' individual perspectives is desirable to facilitate discussion, assessment, and improvement of quality at all stages of clinical research.
- Published
- 2017
- Full Text
- View/download PDF
32. Expression of Myoepithelial Markers in Mammary Carcinomas of 119 Pet Rabbits
- Author
-
Sophie Degner, Heinz-Adolf Schoon, Sebastian Degner, Mathias Baudis, Claudia Schandelmaier, Heike Aupperle-Lellbach, and Sandra Schöniger
- Subjects
calponin ,histopathology ,immunohistochemistry ,mammary carcinoma ,myoepithelial cells ,oryctolagus cuniculus ,pet rabbit ,statistical analysis ,Veterinary medicine ,SF600-1100 ,Zoology ,QL1-991 - Abstract
Most mammary tumors in pet rabbits are carcinomas; prognostic factors are unknown. The aim of this study on rabbit mammary carcinomas was to determine the expression of myoepithelial markers that have a prognostic relevance in human cancers. Mammary carcinomas (n = 119) of female or female-spayed pet rabbits were immunostained for cytokeratin AE1/AE3, vimentin, smooth muscle actin (SMA), and calponin; and percentages of non-neoplastic myoepithelial cells (ME cells) and calponin-positive neoplastic cells were determined. Using statistical analysis, data were correlated with the age of the rabbits and histological tumor characteristics. All carcinomas contained retained spindle-shaped ME, while 115 also contained hypertrophic ME (HME). A statistically significant relationship existed between a higher age and an increase in HME. In 111 carcinomas (93%), tumor cells expressed calponin. There was a significant correlation between higher percentages of calponin-positive tumor cells and a lower mitotic count, an increased percentage of tubular growth, and a lower grading score, respectively. Data suggest that pet rabbit mammary carcinomas develop from progression of in situ cancer and that the extent of calponin expression in tumor cells influences their biological behavior. These results provide the basis for a long-term follow-up on the prognostic significance of calponin expression in mammary cancer cells.
- Published
- 2019
- Full Text
- View/download PDF
33. Distale Femurfrakturen
- Author
-
Schandelmaier, P., Gössling, T., Partenheimer, A., Krettek, C., Bauch, J., editor, Betzler, M., editor, and Lobenhoffer, P., editor
- Published
- 2004
- Full Text
- View/download PDF
34. Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials.
- Author
-
Benjamin Kasenda, Erik von Elm, John J You, Anette Blümle, Yuki Tomonaga, Ramon Saccilotto, Alain Amstutz, Theresa Bengough, Joerg J Meerpohl, Mihaela Stegert, Kelechi K Olu, Kari A O Tikkinen, Ignacio Neumann, Alonso Carrasco-Labra, Markus Faulhaber, Sohail M Mulla, Dominik Mertz, Elie A Akl, Dirk Bassler, Jason W Busse, Ignacio Ferreira-González, Francois Lamontagne, Alain Nordmann, Viktoria Gloy, Heike Raatz, Lorenzo Moja, Shanil Ebrahim, Stefan Schandelmaier, Xin Sun, Per O Vandvik, Bradley C Johnston, Martin A Walter, Bernard Burnand, Matthias Schwenkglenks, Lars G Hemkens, Heiner C Bucher, Gordon H Guyatt, and Matthias Briel
- Subjects
Medicine - Abstract
BackgroundLittle is known about publication agreements between industry and academic investigators in trial protocols and the consistency of these agreements with corresponding statements in publications. We aimed to investigate (i) the existence and types of publication agreements in trial protocols, (ii) the completeness and consistency of the reporting of these agreements in subsequent publications, and (iii) the frequency of co-authorship by industry employees.Methods and findingsWe used a retrospective cohort of randomized clinical trials (RCTs) based on archived protocols approved by six research ethics committees between 13 January 2000 and 25 November 2003. Only RCTs with industry involvement were eligible. We investigated the documentation of publication agreements in RCT protocols and statements in corresponding journal publications. Of 647 eligible RCT protocols, 456 (70.5%) mentioned an agreement regarding publication of results. Of these 456, 393 (86.2%) documented an industry partner's right to disapprove or at least review proposed manuscripts; 39 (8.6%) agreements were without constraints of publication. The remaining 24 (5.3%) protocols referred to separate agreement documents not accessible to us. Of those 432 protocols with an accessible publication agreement, 268 (62.0%) trials were published. Most agreements documented in the protocol were not reported in the subsequent publication (197/268 [73.5%]). Of 71 agreements reported in publications, 52 (73.2%) were concordant with those documented in the protocol. In 14 of 37 (37.8%) publications in which statements suggested unrestricted publication rights, at least one co-author was an industry employee. In 25 protocol-publication pairs, author statements in publications suggested no constraints, but 18 corresponding protocols documented restricting agreements.ConclusionsPublication agreements constraining academic authors' independence are common. Journal articles seldom report on publication agreements, and, if they do, statements can be discrepant with the trial protocol.
- Published
- 2016
- Full Text
- View/download PDF
35. Premature Discontinuation of Prospective Clinical Studies Approved by a Research Ethics Committee - A Comparison of Randomised and Non-Randomised Studies.
- Author
-
Anette Blümle, Stefan Schandelmaier, Patrick Oeller, Benjamin Kasenda, Matthias Briel, Erik von Elm, and DISCO study group
- Subjects
Medicine ,Science - Abstract
Premature discontinuation of clinical studies affects about 25% of randomised controlled trials (RCTs) which raises concerns about waste of scarce resources for research. The risk of discontinuation of non-randomised prospective studies (NPSs) is yet unclear.To compare the proportion of discontinued studies between NPSs and RCTs that received ethical approval.We systematically surveyed prospective longitudinal clinical studies that were approved by a single REC in Freiburg, Germany between 2000 and 2002. We collected study characteristics, identified subsequent publications, and surveyed investigators to elucidate whether a study was discontinued and, if so, why.Of 917 approved studies, 547 were prospective longitudinal studies (306 RCTs and 241 NPSs). NPSs were on average smaller than RCTs, more frequently single centre and pilot studies, and less frequently funded by industry. NPSs were less frequently discontinued than RCTs: 32/221 (14%) versus 78/288 (27%, p
- Published
- 2016
- Full Text
- View/download PDF
36. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
- Author
-
Amstutz, Alain, Speich, Benjamin, Mentré, France, Rueegg, Corina Silvia, Belhadi, Drifa, Assoumou, Lambert, Burdet, Charles, Murthy, Srinivas, Dodd, Lori Elizabeth, Wang, Yeming, Tikkinen, Kari A O, Ader, Florence, Hites, Maya, Bouscambert, Maude, Trabaud, Mary Anne, Fralick, Mike, Lee, Todd C, Pinto, Ruxandra, Barratt-Due, Andreas, Lund-Johansen, Fridtjof, Müller, Fredrik, Nevalainen, Olli P O, Cao, Bin, Bonnett, Tyler, Griessbach, Alexandra, Taji Heravi, Ala, Schönenberger, Christof, Janiaud, Perrine, Werlen, Laura, Aghlmandi, Soheila, Schandelmaier, Stefan, Yazdanpanah, Yazdan, Costagliola, Dominique, Olsen, Inge Christoffer, and Briel, Matthias
- Abstract
Interpretation of the evidence from randomised controlled trials (RCTs) of remdesivir in patients treated in hospital for COVID-19 is conflicting. We aimed to assess the benefits and harms of remdesivir compared with placebo or usual care in these patients, and whether treatment effects differed between prespecified patient subgroups.
- Published
- 2023
- Full Text
- View/download PDF
37. Alternative Osteosynthesetechniken bei offenen Frakturen
- Author
-
Szyszkowitz, R., Grechenig, W., Josten, C., Krettek, C., Schandelmaier, P., Rudolf, J., Könemann, B., Tscherne, H., Braun, W., Mayr, E., Rüter, A., Jukema, G. N., Settner, M., Böhm, H.-J., Hierholzer, G., Siebert, C. H., Höfler, H. R., Hansis, M., Schmittenbecher, P. P., Dietz, H.-G., Hartel, W., editor, and Hierholzer, G.
- Published
- 1995
- Full Text
- View/download PDF
38. Vorbiegung und Vorspannung bei der schmalen 4,5 mm AO Titan LCDCP und der Stahl DCP
- Author
-
Schandelmaier, P., Ungerland, A., Krettek, C., Tscherne, H., and Beger, Hans G., editor
- Published
- 1994
- Full Text
- View/download PDF
39. Attitudes towards evaluation of psychiatric disability claims: a survey of Swiss stakeholders
- Author
-
Stefan Schandelmaier, Andrea Leibold, Katrin Fischer, Ralph Mager, Ulrike Hoffmann-Richter, Monica Susanne Bachmann, Sarah Kedzia, Jason Walter Busse, Gordon Henry Guyatt, Joerg Jeger, Renato Marelli, Wout Ernst Lodewijk De Boer, and Regina Kunz
- Subjects
Disability evaluation (MeSH) ,Insurance Benefits (MeSH) ,Cross-Sectional Studies (MeSH) ,Psychiatry (MeSH) ,Questionnaire (MeSH) ,Switzerland (MeSH) ,Medicine - Abstract
QUESTIONS: In Switzerland, evaluation of work capacity in individuals with mental disorders has come under criticism. We surveyed stakeholders about their concerns and expectations of the current claim process. METHODS: We conducted a nationwide online survey among five stakeholder groups. We asked 37 questions addressing the claim process and the evaluation of work capacity, the maximum acceptable disagreement in judgments on work capacity, and its documentation. RESULTS: Response rate among 704 stakeholders (95 plaintiff lawyers, 285 treating psychiatrists, 129 expert psychiatrists evaluating work capacity, 64 social judges, 131 insurers) varied between 71% and 29%. Of the lawyers, 92% were dissatisfied with the current claim process, as were psychiatrists (73%) and experts (64%), whereas the majority of judges (72%) and insurers (81%) were satisfied. Stakeholders agreed in their concerns, such as the lack of a transparent relationship between the experts’ findings and their conclusions regarding work capacity, medical evaluations inappropriately addressing legal issues, and the experts’ delay in finalising the report. Findings mirror the characteristics that stakeholders consider important for an optimal work capacity evaluation. For a scenario where two experts evaluate the same claimant, stakeholders considered an inter-rater difference of 10%‒20% in work capacity at maximum acceptable. CONCLUSIONS: Plaintiff lawyers, treating psychiatrists and experts perceive major problems in work capacity evaluation of psychiatric claims whereas judges and insurers see the process more positively. Efforts to improve the process should include clarifying the basis on which judgments are made, restricting judgments to areas of expertise, and ensuring prompt submission of evaluations.
- Published
- 2015
- Full Text
- View/download PDF
40. Moderne Osteosyntheseverfahren zur verbesserten Schonung der Fragmentdurchblutung: Marknagelung
- Author
-
Krettek, C., Schandelmaier, P., Pape, C., Tscherne, H., Hartel, W., editor, and Becker, H.-M.
- Published
- 1993
- Full Text
- View/download PDF
41. Störungen der Frakturheilung nach Plattenosteosynthese am Humerus
- Author
-
Haas, N., Schandelmaier, P., Südkamp, N. P., Rahmanzadeh, R., editor, and Meißner, A., editor
- Published
- 1992
- Full Text
- View/download PDF
42. Biomechanik des neuen nicht aufgebohrten massiven AO Unterschenkelverriegelungsnagels und des konventionellen Universalverriegelungsnagels im Vergleich
- Author
-
Schandelmaier, P., Krettek, C., Haas, N., Herfarth, Christian, editor, Betzler, Michael, editor, Quentmeier, Armin, editor, Raute, Michael, editor, Hartel, W., editor, Beger, H. G., editor, and Ungeheuer, E., editor
- Published
- 1991
- Full Text
- View/download PDF
43. Can a Modified Anterior External Fixator Provide Posterior Compression of AP Compression Type III Pelvic Injuries?
- Author
-
Sellei, Richard Martin, Schandelmaier, Peter, Kobbe, Philipp, Knobe, Matthias, and Pape, Hans-Christoph
- Published
- 2013
- Full Text
- View/download PDF
44. Evaluation of work capacity in Switzerland: a survey among psychiatrists about practice and problems
- Author
-
Stefan Schandelmaier, Katrin Fischer, Ralph Mager, Ulrike Hoffmann-Richter, Andrea Leibold, Monica S Bachmann, Sarah Kedzia, Joerg Jeger, Renato Marelli, Regina Kunz, and Wout E. L. De Boer
- Subjects
cross-sectional studies ,disability evaluation ,insurance benefits ,psychiatry ,questionnaire ,Switzerland ,Medicine - Abstract
QUESTIONS UNDER STUDY: In Switzerland, psychiatric evaluations of work capacity for determining a person’s eligibility for disability benefits are being criticised for a lack of transparency and high inter-rater variability. The aims of this study were to learn about the current practice of psychiatrists, to explore possible sources for lack of transparency and variability, and to contrast practice with current professional guidance. METHODS: A national online-survey among psychiatrists who performed five or more evaluations of work capacity per year. Based on discussions with experts and a literature review, we structured questions focusing on reporting on work capacity, the description of a claimant’s previous job, and measures of quality assurance. RESULTS: A total of 129 psychiatrists responded (31% of estimated 412 eligible psychiatrists). The majority reported using instructions of the insurers (77%), peer consulting (65%) and process guidelines (51%). They expressed a claimant’s work capacity as free text and percentage work capacity (49%), percentage only (23%), or free text only (14%). A total of 13% used instruments to document work capacity. Psychiatrists considered three different interpretations of percentage work capacity as equally applicable. A job description was regarded as mandatory to determine work capacity by 90% but only 26% received it and found it mostly deficient. CONCLUSIONS: The transparency and reliability of Swiss psychiatrists’ conclusions on a claimant's work capacity may be reduced by unsystematic reporting, variable interpretation of the percentage work capacity, lack of a detailed job description and insufficient quality control. Education, engagement of insurers and new guidelines might be effective means of implementing improvements.
- Published
- 2013
- Full Text
- View/download PDF
45. Drehfehler nach Unterschenkelmarknagelung und Fixateur Externe
- Author
-
Schandelmaier, P., Krettek, C., Scola, E., Tscherne, H., Hartel, W., editor, and Becker, H.-M.
- Published
- 1993
- Full Text
- View/download PDF
46. Umsetzung und Implementierung eines TraumaNetzwerksD der DGU am Beispiel des TraumaNetzwerks Ostbayern
- Author
-
Ernstberger, A., Leis, A., Dienstknecht, T., Schandelmaier, P., and Nerlich, M.
- Published
- 2009
- Full Text
- View/download PDF
47. Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review
- Author
-
Hirt, Julian, Janiaud, Perrine, Gloy, Viktoria Luise, Schandelmaier, Stefan, Pereira, Tiago V, Contopoulos-Ioannidis, Despina, Goodman, Steven N, Ioannidis, John, Munkholm, Klaus, and Hemkens, Lars G
- Abstract
ObjectiveTo systematically assess the robustness of reported postacute SARS-CoV-2 infection health outcomes in children.MethodsA search on PubMed and Web of Science was conducted to identify studies published up to 22 January 2022 that reported on postacute SARS-CoV-2 infection health outcomes in children (<18 years) with follow-up of ≥2 months since detection of infection or ≥1 month since recovery from acute illness. We assessed the consideration of confounding bias and causality, as well as the risk of bias.Results21 studies including 81 896 children reported up to 97 symptoms with follow-up periods of 2.0–11.5 months. Fifteen studies had no control group. The reported proportion of children with post-COVID syndrome was between 0% and 66.5% in children with SARS-CoV-2 infection (n=16 986) and between 2.0% and 53.3% in children without SARS-CoV-2 infection (n=64 910). Only two studies made a clear causal interpretation of an association between SARS-CoV-2 infection and the main outcome of ‘post-COVID syndrome’ and provided recommendations regarding prevention measures. The robustness of all 21 studies was seriously limited due to an overall critical risk of bias.ConclusionsThe robustness of reported postacute SARS-CoV-2 infection health outcomes in children is seriously limited, at least in all the published articles we could identify. None of the studies provided evidence with reasonable certainty on whether SARS-CoV-2 infection has an impact on postacute health outcomes, let alone to what extent. Children and their families urgently need much more reliable and methodologically robust evidence to address their concerns and improve care.
- Published
- 2023
- Full Text
- View/download PDF
48. Return to work coordination programmes for work disability: a meta-analysis of randomised controlled trials.
- Author
-
Stefan Schandelmaier, Shanil Ebrahim, Susan C A Burkhardt, Wout E L de Boer, Thomas Zumbrunn, Gordon H Guyatt, Jason W Busse, and Regina Kunz
- Subjects
Medicine ,Science - Abstract
The dramatic rise in chronically ill patients on permanent disability benefits threatens the sustainability of social security in high-income countries. Social insurance organizations have started to invest in promising, but costly return to work (RTW) coordination programmes. The benefit, however, remains uncertain. We conducted a systematic review to determine the long-term effectiveness of RTW coordination compared to usual practice in patients at risk for long-term disability.Eligible trials enrolled employees on work absence for at least 4 weeks and randomly assigned them to RTW coordination or to usual practice. We searched 5 databases (to April 2, 2012). Two investigators performed standardised eligibility assessment, study appraisal and data extraction independently and in duplicate. The GRADE framework guided our assessment of confidence in the meta-analytic estimates. We identified 9 trials from 7 countries, 8 focusing on musculoskeletal, and 1 on mental complaints. Most trials followed participants for 12 months or less. No trial assessed permanent disability. Moderate quality evidence suggests a benefit of RTW coordination on proportion at work at end of follow-up (risk ratio = 1.08, 95% CI = 1.03 to 1.13; absolute effect = 5 in 100 additional individuals returning to work, 95% CI = 2 to 8), overall function (mean difference [MD] on a 0 to 100 scale = 5.2, 95% CI = 2.4 to 8.0; minimal important difference [MID] = 10), physical function (MD = 5.3, 95% CI = 1.4 to 9.1; MID = 8.4), mental function (MD = 3.1, 95% CI = 0.7 to 5.6; MID = 7.3) and pain (MD = 6.1, 95% CI = 3.1 to 9.2; MID = 10).Moderate quality evidence suggests that RTW coordination results in small relative, but likely important absolute benefits in the likelihood of disabled or sick-listed patients returning to work, and associated small improvements in function and pain. Future research should explore whether the limited effects persist, and whether the programmes are cost effective in the long term.
- Published
- 2012
- Full Text
- View/download PDF
49. Fraktur des medialen Femurkondylus als Komplikation bei der Entfernung eines retrograden Femurnagels
- Author
-
Grimme, K., Gosling, T., Pape, H. C., Schandelmaier, P., and Krettek, C.
- Published
- 2004
- Full Text
- View/download PDF
50. Distale Femurfrakturen
- Author
-
Schandelmaier, P., Gössling, T., Partenheimer, A., and Krettek, C.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.